Table 1 Sample descriptives (N = 3,552)
2017 | 2018 | 2019 | |
|---|---|---|---|
Viral suppression | |||
Suppressed | 2040 (57.4%) | 2075 (58.4%) | 1971 (55.5%) |
Unsuppressed | 1080 (30.4%) | 1061 (29.9%) | 1044 (29.4%) |
Missing | 432 (12.2%) | 416 (11.7%) | 537 (15.1%) |
Number of viral load records | |||
Mean (SD) | 3.4 (1.9) | 3.2 (1.6) | 3.1 (1.5) |
No change in suppression | 2351 (66.2%) | 2422 (68.2%) | 2307 (65.0%) |
Adherence level | |||
< 50% | 175 (4.9%) | 166 (4.7%) | 203 (5.7%) |
> 50–80% | 498 (14.0%) | 477 (13.4%) | 457 (12.9%) |
> 80–90% | 412 (11.6%) | 452 (12.7%) | 401 (11.3%) |
> 90–95% | 432 (12.2%) | 425 (11.7%) | 403 (11.3%) |
> 95% | 1921 (54.1%) | 1937 (54.5%) | 1963 (55.3%) |
Missing | 115 (3.2%) | 106 (3.0%) | 125 (3.5%) |
Number of quarters with ART regimen switches | |||
0 switches | 2486 (70.0%) | 2195 (61.8%) | 2241 (63.1%) |
1 switch | 611 (17.2%) | 685 (19.3%) | 704 (19.8%) |
2 switches | 409 (11.5%) | 549 (15.5%) | 506 (14.2%) |
3 + switches | 46 (1.3%) | 123 (3.4%) | 101 (2.8%) |
Mean (SD) | 0.441 (0.745) | 0.612 (0.891) | 0.573 (0.855) |
Single-tablet regimen (STR) | 1953 (55.5%) | 2146 (60.4%) | 2498 (70.3%) |
Total ART medication fills | |||
Mean (SD) | 19.2 (11.4) | 18.2 (10.6) | 16.1 (9.4) |
Nadir CD4 | |||
>=200 | 2727 (76.8%) | ||
< 200 | 825 (23.2%) | ||
Number of physical comorbidities | |||
Mean (SD) | 1.55 (1.43) | ||
Number of mental/behavioral conditions | |||
Mean (SD) | 2.34 (1.98) | ||
Age categories | |||
18–29 | 475 (13.4%) | ||
30–49 | 2027 (57.1%) | ||
50+ | 1044 (29.4%) | ||
Missing | 6 (0.2%) | ||
Race/ethnicity | |||
Non-Hispanic Black | 1925 (54.2%) | ||
Non-Hispanic White | 273 (7.7%) | ||
Hispanic | 1258 (35.4%) | ||
Non-Hispanic Other | 80 (2.2%) | ||
Missing | 16 (0.5%) | ||
Gender identity | |||
Cis female | 1148 (32.3%) | ||
Cis male | 2239 (63.0%) | ||
Transgender | 165 (4.6%) | ||
Housing status | |||
Stable housing | 3460 (97.4%) | ||
Unstably housed | 92 (2.6%) | ||